Levodopa availability improves with progression of Parkinson’s disease
✍ Scribed by Dirk Woitalla; Oliver Goetze; Jeong I. Kim; Alice B. Nikodem; Wolfgang E. Schmidt; Horst Przuntek; Thomas Müller
- Book ID
- 106093328
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 108 KB
- Volume
- 253
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The objective was to investigate the impact of exercise on absorption and efficacy of levodopa (LD) in patients with Parkinson‘s disease (PD). A soluble, immediate release LD formulation was given followed by exercise near the aerobic limit on one day to PD patients, who underwent the s
OBJECTIVE: To monitor comparative progression of clinical impairment over 4 years in patients with Parkinson's disease (PD) who present on levodopa at two different levels of Hoehn and Yahr (HY) stages, II and III. BACKGROUND: The rate of clinical impairment progression in patients with PD being tr